Form 4: CME Group Inc. Executive Jonathan L. Marcus Sells 390 Shares Under 10b5-1 Plan
SEC Form 4
Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., sold 390 shares of Common Stock Class A at $277.5 per share on May 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 20, 2025, Jonathan L. Marcus, a Senior Managing Director and General Counsel at CME Group Inc., sold 390 shares of Common Stock Class A.
- The sale was executed at a price of $277.5 per share.
- Following the transaction, Marcus directly owns 6,708 shares of CME Group Inc. Common Stock Class A.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 18, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction. Rule 10b5-1 plans are commonly used by corporate insiders to sell shares over time, avoiding accusations of trading on non-public information.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder confidence, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date the reporting person adopted the Rule 10b5-1 plan |
| 05/20/2025 | Date of the transaction (stock sale) |
| 05/21/2025 | Date of signature for the Form 4 filing |
Keywords
CME Group Inc., Jonathan L. Marcus, Form 4, insider trading, Rule 10b5-1, stock sale, Common Stock Class A
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.